| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $9.3M | -38.6% |
| SG&A Expense | $5.5M | -27.0% |
| Net Income | -$14.6M | +35.4% |
| EPS (Basic) | -$9.27 | -1682.7% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | -87.0% |
| Current Assets | $3.3M | -75.3% |
| Total Assets | $4.0M | -75.1% |
| Current Liabilities | $3.1M | -22.8% |
| Total Liabilities | $3.2M | -21.8% |
| Stockholders' Equity | $731K | -93.8% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.9M | +41.8% |
| Investing Cash Flow | -$232K | — |
| Financing Cash Flow | $1.9M | -91.4% |